MedTrace Logo

InRAD Observational Study

NCT07213700 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50000

Last updated 2026-04-16

No results posted yet for this study

Summary

The goal of this international observational study is to evaluate long-term disease outcomes and treatment safety in people with Alzheimer's disease (PwAD), by collecting real-world data from routine clinical practice across global clinical centers.

The InRAD Registry Observational Study has several aims:

* To collect medical information for many years from a large group of people with Alzheimer's disease. This will be used for research, which will support improved understanding about the disease.
* To enable researchers to look at the effectiveness, usefulness and safety of treatments for Alzheimer's disease.
* To enable researchers to answer similar research questions and compare results in many different areas of the world.

People with Alzheimer's disease who meet the eligibility criteria and agree to participate in the Study will be asked to visit their doctor (e.g. psychiatrist, geriatrician, or neurologist) at least once a year, or as frequently as is needed for their care. During or after their appointments they may be offered assessments, tests, medications, and treatments as determined by their doctor and their team. This is an observational data collection.

Conditions

  • Alzheimer's Disease(AD)
  • Mild Cognitive Impairment (MCI)
  • Subjective Cognitive Decline (SCD)
  • Non-Alzheimer Degenerative Dementia

Interventions

OTHER

None, this is a non-interventional observational study

None applicable

Sponsors & Collaborators

  • InRAD Foundation (Data Processor)

    collaborator UNKNOWN

  • All Individual Principal Investigators and their centers (Data Controllers)

    collaborator UNKNOWN

  • Stichting International Registry for Alzheimer's Disease and other Dementias Foundation

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-30
Primary Completion
2036-01-31
Completion
2036-01-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07213700 on ClinicalTrials.gov